Although there’s plenty of positive vaccine news to go around, the latest government press conference offered a sobering reminder of the obstacles that remain when it comes to ensuring a successful vaccination programme. The Health Secretary said that despite recent efforts to prevent new arrivals to the UK bringing in the South African variant, random check found 11 cases that could not be linked to international travel. This means there has been community transmission.
While Hancock said there was ‘currently no evidence’ to suggest this variant is more severe, its emergence is of concern across government. The reason? The effect of vaccines on the new strain. Early data from two new coronavirus vaccine trials — Novavax and Johnson & Johnson — suggested they have lower efficacy against the South African variant.
Speaking today, Public Health England’s Susan Hopkins said three of the vaccines used to date in trials have shown they are still effective against it ‘at a level greater than the minimum standard set by the WHO’.
Get Britain's best politics newsletters
Register to get The Spectator's insight and opinion straight to your inbox. You can then read two free articles each week.
Already a subscriber? Log in
Comments
Join the debate for just £1 a month
Be part of the conversation with other Spectator readers by getting your first three months for £3.
UNLOCK ACCESS Just £1 a monthAlready a subscriber? Log in